NRx Pharmaceuticals, Inc.
NRXP
$3.37
-$0.10-2.88%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 297.53% | -13.90% | 8.53% | 146.87% | -47.55% |
| Total Receivables | 13.81% | 12.42% | -95.16% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 395.42% | -59.32% | -58.94% | 56.37% | -9.46% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 374.45% | -34.01% | -- | -- | 9.81% |
| Total Current Assets | 296.11% | -17.22% | -25.57% | 160.28% | -36.74% |
|
|
|||||
| Total Current Assets | 296.11% | -17.22% | -25.57% | 160.28% | -36.74% |
| Net Property, Plant & Equipment | 46.53% | 71.70% | 66.11% | 5,137.50% | -- |
| Long-term Investments | 0.00% | 0.00% | 193.93% | -- | -- |
| Goodwill | 0.00% | 0.00% | 193.93% | -- | -- |
| Total Other Intangibles | -5.35% | -4.97% | -47.95% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -18.84% | 9.09% | 4.12% | 1.25% | -28.14% |
| Total Assets | 186.99% | -8.13% | -13.60% | 209.96% | -36.26% |
|
|
|||||
| Total Accounts Payable | -28.48% | 3.02% | 0.31% | 17.27% | -15.80% |
| Total Accrued Expenses | 10.91% | -3.52% | 2.74% | -8.62% | 9.35% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.32% | 23.73% | -96.87% | 2.48% | 17.35% |
| Total Finance Division Other Current Liabilities | 62.64% | -18.55% | -11.54% | -1.02% | 44.03% |
| Total Other Current Liabilities | 62.64% | -18.55% | -11.54% | -1.02% | 44.03% |
| Total Current Liabilities | 34.55% | -11.90% | -29.60% | 0.35% | 23.52% |
|
|
|||||
| Total Current Liabilities | 34.55% | -11.90% | -29.60% | 0.35% | 23.52% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -16.02% | 72.38% | 99.37% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 33.48% | -10.99% | -29.10% | 0.74% | 23.52% |
|
|
|||||
| Common Stock & APIC | 10.24% | 1.22% | 3.36% | 5.93% | 2.76% |
| Retained Earnings | -5.36% | -0.47% | 0.12% | -1.95% | -6.20% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 98.77% | 13.31% | 38.12% | 27.68% | -41.55% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 98.77% | 13.31% | 38.12% | 27.68% | -41.55% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 98.77% | 13.31% | 38.12% | 27.68% | -41.55% |
|
|
|||||